Publication date: Available online 15 February 2019
Source: The Journal of Allergy and Clinical Immunology: In Practice
Author(s): Patrick W. Sullivan, Ghushchyan Vahram, Kavati Abhishek, Navaratnam Prakash, Howard S. Friedman, Ortiz Benjamin
Abstract
Background
Examining national trends in asthma treatment and control is essential to inform treatment and public health initiatives.
Objective
Explore national trends in asthma control and treatment over time among children and those residing in poor-urban areas.
Methods
This was an analysis of trends from 2003-2014 among children (aged 1-17) in the Medical Expenditure Panel Survey (MEPS). Indicators of poor control included use of >3 canisters short-acting beta agonist (SABA) in 3 months, asthma attack, Emergency Department (ED)/inpatient (IP) hospitalization and systemic corticosteroids (SCS). Treatment included inhaled corticosteroids (ICS), controller medications, SABA and ratio of controller-to-total prescriptions ≥ 0.7. Other measures included the number of asthma medications, outpatient visits, asthma-specific drug and total expenditures per-patient-per-year.
Results
There were 8.4 million children with asthma in the U.S. in 2014; 11.1% lived in poor-urban areas. There was a statistically significant decrease in the percentage of children using ICS, controller medications, daily preventive medications, SCS, SABA, > 3 canisters SABA (in 3 months), overall asthma prescriptions and outpatient visits. There was a significant increase in the percentage of children reporting having an asthma attack. Trends for children residing in poor-urban areas were compared to all others, however, limited data and variability in annual estimates prevent clear conclusions.
Conclusion
Results suggest lack of improvement in treatment and control since 2003 among children with asthma in the U.S. There is significant room for improvement in asthma control and disease management among children.
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2UYJP75
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.